Company page
Hls Therapeutics, Inc.
Hls Therapeutics, Inc. is a publicly traded company on the Canadian market under the ticker HLS. The company has a market capitalization of approximately CAD 94.9 million. Hls Therapeutics focuses on developing and commercializing innovative pharmaceutical products.
- Ticker
- HLS:TSX
- Asset type
- Stock
- Market cap
- $94.9M
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- TSX
- Currency
- CAD